Breaking News on Global Pharmaceutical Technology & Manufacturing

Headlines > February 2007

« Previous month Next month »

28-Feb-2007

Baxter given the go-ahead for banned infusion pump

28-Feb-2007 - The US Food and Drug Administration (FDA) has given Baxter Healthcare the go ahead for a modified version of the company's Colleague volumetric infusion pump that was the subject of...

New service to protect packaged pharmaceutical products

28-Feb-2007 - Multisorb Technologies has introduced a new advanced simulation service to help pharmaceutical companies determine the precise amount of sorbent needed in their packaging to protect products from moisture and degradation.

European Commission to revamp drug safety monitoring system

28-Feb-2007 - The European Commission has announced it plans to revamp the current EU drug safety monitoring system in order to make it more efficient.

Aptuit embarks on $100m spending spree

28-Feb-2007 - Drug development services provider Aptuit has announced it is about to invest $100m to expand its operations, just a few weeks after completing two major acquisitions.

Cell preservation technology could reduce animal experiments

28-Feb-2007 - A technology designed to preserve living cells for longer could significantly reduce the number of animals used in medical research, according to its creators Abcellute.

Contract biomanufacturing market continues to climb

28-Feb-2007 - The biopharmaceutical contract manufacturing sector is set to expand substantially in the next few years as biotech companies increasingly rely on outsourcing to improve efficiency and reduce costs, new research...

UK firms join forces for spray device testing

28-Feb-2007 - UK firms Melbourn Scientific and Copley Scientific have agreed to collaborate on developing novel methods of testing the force of nasal sprays and metered-dose inhalers (MDIs).

Space-saving ceiling-mounted robot

28-Feb-2007 - Adept Technology has introduced a ceiling-mounted version of its s800 series Cobra robot. The inverted robot offers high-speed packaging and assembly with a wider reach, while leaving a much clearer...

27-Feb-2007

Alpha strengthens plastics portfolio

27-Feb-2007 - Alpha Packaging has bought fellow US company Quality Container, a specialist in plastic bottles for pharmaceutical and dietary supplement products, for an undisclosed sum.

Exubera helps boost West's 2006 results

27-Feb-2007 - West Pharmaceutical Services posted healthy financial results for 2006, with sales of the inhalable insulin device for Pfizer's Exubera significantly contributing to the results reported by the firm's Tech Group...

Nicholas Piramal announces funding for planned US assault

27-Feb-2007 - Nicholas Piramal has announced it will spend $50m (€38m) on its formulations services business over the next three years, part of which will be used to fund its planned assault...

Sweden next to be hit by AstraZeneca job cuts

27-Feb-2007 - 850 jobs are set to be cut across AstraZeneca's Swedish sites, on top of the previously announced 450 already due to be lost in the country over the course of 2007.

New 'caged DNA' system to deliver drugs

27-Feb-2007 - Researchers have come up with a new 'caged DNA' material, combining DNA macromolecules with polymers containing iron, which represents a novel drug delivery system for gene therapy.

World's first digital insulin pen with memory

27-Feb-2007 - Eli Lilly has come up with a new insulin pen with a digital display that allows patients to record and review the time, date and dose of the last 16...

26-Feb-2007

European healthcare firms recognised at Frost & Sullivan awards

26-Feb-2007 - Companies making outstanding contributions to the healthcare industry were honoured last week at a glittering awards evening celebrating Frost & Sullivan's Excellence in Healthcare awards, 2006.

Sartorius takes on Stedim

26-Feb-2007 - German firm Sartorius has merged its biotech unit with biopharmaceutical supplier Stedim Biosystems, forming a company anticipated to generate sales of €400-420m during 2007.

Outsourcing packaging can increase speed to market four-fold

26-Feb-2007 - Using contractors to fulfil packaging needs can significantly reduce the time new products take to hit the market, claimed Gareth Lewis of Cardinal Health, speaking at SMi's Pharmaceutical Packaging and...

Terapia Ranbaxy linked to EU norms

26-Feb-2007 - Ranbaxy has been granted an EU manufacturing and import license for its Romania-based Terapia Ranbaxy subsidiary, and says it will make the company a strategic regional hub for its operations...

Ajinomoto ups L-Arginine price

26-Feb-2007 - Amino acid manufacturer Ajinomoto Aminoscience announced that increasing raw material and energy costs have driven the company to increase prices of its L-Arginine products by $1/ kg.

People on the move: pharmaceutical manufacturing

26-Feb-2007 - Merck, Pfizer, Sanofi-Aventis and Wyeth have all had people on the move in the world of pharmaceutical manufacturing.

23-Feb-2007

Product News In Brief 23.02.07

23-Feb-2007 - A round up of recent product releases from across the industry.

Invetech increase lab efficiency

23-Feb-2007 - A new process engineering service aims to improve workflow efficiency by using advanced models to identify and eliminate laboratory bottlenecks and plan for future changes.

Biochemical chip solves cell-mating puzzle

23-Feb-2007 - Scientists have used a biochemical chip to explain the important role a certain protein plays in the mating habits of yeast cells. The finding could lead to new cancer drugs...

Thousands of ways to tackle flu

23-Feb-2007 - A milestone in the fight against both human and bird flu could help scientists develop new vaccines and therapies against the virus, preparing the world in case of a pandemic.

22-Feb-2007

Bill to stop generic pay-offs

22-Feb-2007 - The Senate Judiciary Committee last week approved legislation that would prevent drug manufacturers from paying off firms to delay entry of generic versions of their products onto the market.

Dyax and Genzyme agrees to terminate DX-88 contract

22-Feb-2007 - Dyax announced that it has reached a mutual agreement with Genzyme to terminate their joint venture for the development and commercialization of DX-88 for hereditary angioedema (HAE).

Smopex scavenges for metal

22-Feb-2007 - Johnson Matthey's metal scavenging system, Smopex, is designed to remove precious metals at high speed from solutions and active pharmaceutical ingredients (APIs).

GlaxoSmithKline watches your weight

22-Feb-2007 - GlaxoSmithKline (GSK) has acquired licensing rights outside the US to the over the counter (OTC) weight-loss medication orlistat, previously marketed by Roche.

AZ's Macclesfield site first on the chopping block

22-Feb-2007 - AstraZeneca has this week announced 700 job losses the firm's Macclesfield site in the UK. Representing over a quarter of the site's workforce, the cuts come as part of the...

Leaner Cambrex sharpens focus on high potency

22-Feb-2007 - After shedding two of its unwanted divisions, a leaner Cambrex has decided to channel its energy into its high potency development (HiPO) business.

Pharmas to lose $100bn to generics

22-Feb-2007 - A report to be published next week predicts that US and EU pharmas will lose up to $100bn in revenues over the next five years as generic products take advantage...

21-Feb-2007

Government protects the public from terrorist attacks

21-Feb-2007 - New US legislation comes into force on 4 April 2007, which will reduce dangerous chemicals to fall into the hands of terrorists.

Galapagos inks cancer research contract with UK University

21-Feb-2007 - Galapagos has inked a drug discovery contract with the University of Bristol in which the firm will provide services to help the university accelerate its anti-cancer research programme.

Almac forms alliance with BioCatalytics on chiral tech

21-Feb-2007 - Pharmaceutical services group Almac Sciences has teamed up with enzyme catalyst firm BioCatalytics on process development and manufacture of chiral intermediates and active pharmaceutical ingredients (APIs).

Contract manufacturing news in brief

21-Feb-2007 - QSV, Novasep and Cytovance have all announced new contract manufacturing deals this week, while Hyaluron has unveiled its production plant expansion.

Circuit printing technology enters the market

21-Feb-2007 - Advances in organic electronics have allowed UK-based Novalia to develop a proprietary technology for circuit printing on packaging - using conventional printing equipment - which can be used to identify...

20-Feb-2007

FDA requests more funds

20-Feb-2007 - The Food and Drug Administration (FDA) have high hopes for the fourth revision of the Prescription Drug User Fee Act (PDUFA), which has proved its worth by cutting review times...

Abraxis hauled up for contamination and misbranding

20-Feb-2007 - US firm Abraxis BioScience has been issued a firm warning by the Food and Drug Administration (FDA) following concerns about contamination of drug products and marketing violations for several drugs.

New biologics facility for BMS

20-Feb-2007 - Bristol-Myers Squibb (BMS) has spent $3.65m (€2.78m) on an 89-acre plot of land to build a new bulk biologics manufacturing facility in Devens, Massachusetts.

Codex panels seek out enzymes

20-Feb-2007 - Biotechnology firm Codexis has launched its Codex biocatalyst panels, which promise to increase R&D and manufacturing productivity while reducing cost.

WHO fears over global flu vaccine production capacity

20-Feb-2007 - The World Health Organisation (WHO) last week reiterated its concerns regarding the worldwide lack of manufacturing capacity in the face of the potential global pandemic influenza vaccine demand.

Competition drives compliance battle among CMOs

20-Feb-2007 - Global compliance is becoming a key differentiator for contract manufacturing organisations (CMOs) who want to stay ahead of the game in the buoyant but competitive active pharmaceutical ingredients (APIs) manufacturing...

Heavy brines serve as 'green' solvent

20-Feb-2007 - Israeli-based Chemada has announced that heavy brines can be used as solvent in pharmaceutical applications to cut waste and costs. The company made the announcement at last week's InformexUSA show...

19-Feb-2007

SAFC and Excelsyn beef up UK operations

19-Feb-2007 - Excelsyn and SAFC Both announced improvements to their UK contract manufacturing operations at this year's pharma services and specialty chemicals trade show, InformexUSA, in San Francisco.

French law disallows 'generic' biosimilars

19-Feb-2007 - The French Parliament has adopted legislation which prevents biosimilar medicinal products from being classed as generics and bans the automatic substitution of one biological medicine for another.

Ranbaxy raided by US officials

19-Feb-2007 - The US offices of Indian pharmaceutical company Ranbaxy were subjected to a search by federal officials the company reported last week.

DSM Pharma & Crucell reach milestone in antibody production

19-Feb-2007 - The collaboration between DSM Pharmaceutical Products and biotechnology firm Crucell has raised the bar for antibody production, whilst decreasing manufacturing costs.

First SafeBridge certification awarded in Europe

19-Feb-2007 - Northern Ireland-based Almac Services has recently been awarded a potent compound safety certification by SafeBridge, confirming that Almac is capable of handling potent compounds safely and is able to limit...

16-Feb-2007

Product News in Brief 16.02.07

16-Feb-2007 - A round up of recent product releases from across the industry.

Syrris to double sales force

16-Feb-2007 - High demand of Syrris' batch and flow chemistry reactors has forced them to double their sales force to cope with demand.

Next generation DNA microarray to aid drug discovery

16-Feb-2007 - The new 'whole' DNA microarray promises to lower the cost and increase the speed of drug discovery processes.

15-Feb-2007

Generic biologics to hit US market

15-Feb-2007 - A bill unveiled by US senators yesterday would clear the way for the Food and Drug Administration (FDA) to approve low cost, generic versions of biotech medicines. There is currently...

Invitrogen sells 'beleaguered' BioReliance

15-Feb-2007 - Invitrogen has decided to sell BioReliance, the 'beleaguered' pharmaceutical services arm of its business, for less than half the price they paid for it just three years ago.

DSM achieves record sales in '06, but cautious on '07 outlook

15-Feb-2007 - Dutch chemicals and ingredients manufacturer DSM has posted record end of year results with €809m operating profit, up six per cent on 2005.

Actavis gains new contract manufacturing capabilities in India

15-Feb-2007 - Actavis has waded further into India and picked up new contract manufacturing capabilities along the way with the purchase of a division of Sanmar Specialty Chemicals (SSCL).

New cost-cutting cancer drug delivery system

15-Feb-2007 - A Japanese firm announced this week that it has developed a biodegradable polymer based drug delivery system that could significantly improve the efficacy of chemotherapy drugs and reduce drug development...

Pharma continue to go 'green' with Materia's catalysts

15-Feb-2007 - Materia's metathesis platform continues to excite the pharmaceutical industry as they follow their recent license to Merck with a license to Aileron Therapeutics.

14-Feb-2007

Geneservice arrives in Oxford

14-Feb-2007 - UK contract research organisation (CRO) Geneservice has announced its acquisition of the DNA sequencing facility in the University of Oxford's Biochemistry Department.

ISPE publishes guide on water and steam systems

14-Feb-2007 - The International Society for Pharmaceutical Engineering (ISPE) has released its latest industry guide, covering the commissioning and qualification of pharmaceutical water and steam systems.

Albany Molecular Research dips further into the red

14-Feb-2007 - Albany Molecular Research (AMRI) has slipped again in the fourth quarter of 2006 recording an operating loss of $2.5m (€1.9m) - six per cent worse than the same quarter the...

Free trade to save EU pharmas €230m

14-Feb-2007 - A new international agreement will eliminate customs duties on pharmaceuticals and chemical intermediates traded between the major nations dealing in the industry. The move is set to save EU pharmaceutical...

13-Feb-2007

FDA pulls up Omnicare on quality violations

13-Feb-2007 - The US Food and Drug Administration (FDA) have issued Kentucky-based Omnicare with a blunt warning letter outlining the firm's quality and safety lapses at its repackaging facility in Toledo.

Valois valve in insulin device

13-Feb-2007 - French firm Valois Pharma will be providing Generex with a novel valve for its pressurised metered dose inhaler (pMDI), used for its innovative method of buccal delivery of insulin.

Put that in your pipeline and smoke it...

13-Feb-2007 - Therapeutic drugs can now be smoked like cigarettes thanks to a novel drug delivery device developed by new player Alexza Pharmaceuticals. The inhaled drugs hit the bloodstream much quicker than...

Indian-Irish biosimilar partnership to provide new European CMO contracts

13-Feb-2007 - A new partnership between India's Reliance Life Sciences (RLS) and Ireland's GeneMedix will provide new contract opportunities for European contract bio-manufacturers.

QuitPak enters pilot study

13-Feb-2007 - A combination therapy to help smokers kick the habit has begun evaluation in Phase I pilot studies in the US. A sustained-release formulation of Cary Pharmaceutical's QuitPak has been developed...

12-Feb-2007

Dental implant keeps tabs on drug intake

12-Feb-2007 - European scientists have introduced a dental prosthesis capable of dosing drugs, which they suggest could be a more convenient option than swallowing pills.

SCOLR drops phenylephrine plans

12-Feb-2007 - US firm SCOLR Pharma has dropped development plans for a controlled release phenylephrine (PE) formulation, in light of slow progress in the over-the-counter (OTC) PE market.

Irish plants latest casualty as Pfizer trims API manufacturing

12-Feb-2007 - Heavyweight Pfizer is the latest pharmaceutical to cut manufacturing capacity and shut down plants as it announces the closure and sale of active pharmaceutical ingredient (API) facilities in Ireland.

09-Feb-2007

Applied Biosystems preparing to go SOLiD

09-Feb-2007 - Applied Biosystems are soon to launch their next generation genetic analysis platform into a market that should allow a whole new wave of biological understanding.

A Happy New Year for the UK lab equipment market?

09-Feb-2007 - Bigger is not necessarily better in the UK's laboratory equipment market, with smaller firms often outperforming their larger rivals.

Exploiting natural HIV defence

09-Feb-2007 - A naturally occurring molecule helps protect the immune system from being destroyed by HIV and could open up a new way of fighting the effects of the virus, according to...

08-Feb-2007

Protection for vaccine manufacturers

08-Feb-2007 - Pharmaceutical companies manufacturing vaccines to protect against avian flu outbreaks will be protected from product liability claims according to new regulations announced by the US Department of Health and Human...

Mediatech adds biotech filling systems to its portfolio

08-Feb-2007 - US-based sterile experts Mediatech has entered into a business agreement with US-based packaging and filling supplier Rapak to market and sell aseptic filling equipment to satisfy a gap in the...

Bespak inks deal for migraine treatment

08-Feb-2007 - UK medical device firm Bespak has signed an agreement with new player Zogenix for development of a fast-acting migraine treatment.

Bonfiglioli sees through pre-filled syringes

08-Feb-2007 - Italy's Bonfiglioli Engineering has launched a leak testing machine for syringes, with the ability to check and remove syringes that are faulty before leaving the factory.

Carbon nanoneedles for drug delivery

08-Feb-2007 - A multinational team of researchers based in the UK has found a way to make carbon nanotubes easily cross biological barriers, opening up the potential for a new form of...

Contract manufacturing news in brief

08-Feb-2007 - Inyx, Cobra and EaglePicher have all featured in new contract manufacturing announcements in the past week.

Indian firm, Ranbaxy, eyes up biosimilars

08-Feb-2007 - Indian generics company Ranbaxy Laboratories has signed a development and marketing agreement with generic injectables company Zenotech Laboratories to produce its first biosimilar, a granulocyte-colony stimulating factor (G-CSF; filgrastim), leading...

07-Feb-2007

MFIC reports revenues boosted by microfluidics

07-Feb-2007 - US-based nanotech process provider MFIC has announced a 35 per cent increase in revenue over the full-year 2006 to $15.7m (€12.1m), driven by a rising demand from drugmakers for microfluidics products.

Cardinal Health placates FDA with Alaris pump action

07-Feb-2007 - Cardinal Health has reached an agreement with the US Food and Drug Administration (FDA) on plans to resume manufacture and sale of its Alaris (SE) line of infusion pumps. Units...

Lonza snaps up Cambrex 'bio businesses'

07-Feb-2007 - Contract manufacturer Lonza has completed its acquisition of two Cambrex subsidiaries, research bioproducts and microbial biopharmaceutical, in a move that is fuelled by its strategic move into biopharmaceuticals.

Laureate and Boehringer in bioprocessing partnership

07-Feb-2007 - Laureate Pharma will now offer extra bioprocessing services to its customers following a new partnership deal signed with Boehringer Ingelheim.

New easy-to-use closure for patients with limited hand function

07-Feb-2007 - Swedish packaging manufacturer Cerbo has developed a novel closure for tablet bottles as a user-friendly alternative for those who have limited dexterity in their hands and fingers.

Legumes encapsulate oral antifungal drug

07-Feb-2007 - US-based drug delivery firm, BioDelivery Sciences International (BDSI), has asked for approval to start clinical trials of a soya bean-based delivery technology that would lead to the first oral version...

BioProgress taps TabWrap potential

07-Feb-2007 - UK-based firm BioProgress has developed novel tablet cores that mean pills which were previously very difficult to coat can be reformulated and easily coated using the company's innovative TabWrap technology.

06-Feb-2007

FDA to settle Citizen's Petitions against Wyeth

06-Feb-2007 - US Food and Drug Administration (FDA) has until April 2007 to reply to a Citizen's Petition (CP) filed by Orchid Chemicals in response to accusations of 'evergreening' related to Wyeth's...

Democrats determined to see 'biogeneric' bill through

06-Feb-2007 - US Democrats spearheaded by Henry Waxman intend to re-table a stalled piece of legislation that would allow US Food and Drug Administration (FDA) approval of generic biodrugs, which they claim...

MDS Pharma closes Quebec facility following FDA probe

06-Feb-2007 - MDS pharma has ceased operations at its bioanalytical services facility in Blainville, Quebec in a bid to boost profitability after an ongoing investigation of the site by the US Food...

Tolmar in sale-leaseback deal to snap up QLT USA

06-Feb-2007 - Private pharmaceutical firm Tolmar has sold off its pharmaceutical manufacturing plant in a move to fund the purchase of the US assets of biopharmaceutical QLT. The plant, sold for $13.6m...

Pump technology sustains insulin patch

06-Feb-2007 - US-based start-up company Medipacs is developing a miniaturised digital pump, no bigger than a quarter, which could become the first patch-like product to help diabetics manage their insulin therapy.

Pharma industry to reap rewards from government security tech

06-Feb-2007 - A security technology that had been strictly limited to use by governmental organisations is now available commercially, with several major pharmaceutical manufacturers keen to snap up the device and protect...

Wyeth pens three deals in a day

06-Feb-2007 - Wyeth Pharmaceuticals is expanding its research into delivery systems for haemophilia drugs through a collaboration deal with MediVas.

05-Feb-2007

Millipore reports Q4 income surge

05-Feb-2007 - US-based biopharmaceutical product providers Millipore has met its revenue and earnings target over the fiscal year, helped by its Serologicals acquisition in the fourth quarter and a solid performance by...

AstraZeneca's job cuts latest symptom of widespread trend

05-Feb-2007 - Pharma giant AstraZeneca last week announced its intention to cut 3,000 jobs in an effort to increase productivity and reduce costs. The company is the latest big pharma to trim...

New inhaler is child's play

05-Feb-2007 - A new inhaler with a child-friendly design aims to solve the problem of dosage variance and patient compliance - key issues with inhaled drug treatments for children.

UK organisation issues hazardous waste advice

05-Feb-2007 - A UK-based firm is offering advice to chemical and pharmaceutical companies on reducing hazardous waste and adhering to the Registration, Evaluation and Authorisation of Chemicals Regulation (REACH), which becomes law...

Rockwell invests in Ireland

05-Feb-2007 - US-based Rockwell Automation has acquired Irish engineering firm ProsCon Holdings in a strategy to move into the European pharmaceutical market.

02-Feb-2007

Roche Diagnostics and 454 launch next generation sequencer

02-Feb-2007 - The first next generation sequencer from Roche and 454 is already proving popular only weeks after its release.

Pfizer plans to double drug production outsourcing

02-Feb-2007 - Pfizer's latest cutbacks will provide a new outsourcing opportunity for contract manufacturing organisations (CMOs) in low-cost destinations as the drug giant announces plans to double its amount of drug production...

Multiplexed microfluidic separations

02-Feb-2007 - A new 'lab-on-a-chip' electrophoresis separation device allows higher resolution separations and could enable faster diabetes immunoassay diagnoses.

01-Feb-2007

Disposables prove lucrative for Sartorius

01-Feb-2007 - Sartorius has reported 7.6 per cent increase in sales revenue in 2006 rising to €520.1m ($677.4m), due to the biotechnology division's decision to focus on disposable systems.

GSK invests in new Irish facility

01-Feb-2007 - Major pharmaceutical player GlaxoSmithKline (GSK) has begun construction of a €23m facility in County Waterford, Ireland. The new facility is already under construction at the company's consumer healthcare manufacturing site...

Dalton moves into commercial manufacturing services

01-Feb-2007 - Canada's Dalton Pharma Services has been given the green light to start offering commercial sterile manufacturing services to its pharma customers.

Copycat heart drug in Thailand

01-Feb-2007 - The army-appointed Thai government has invoked a rule under the World Trade Organisation (WTO) to break patents and supply generic versions of drugs to treat heart disease.

Steris posts mixed 3Q results

01-Feb-2007 - US-based sterilisation system providers Steris this week announced their fiscal 2007 third quarter results, revealing the impact of the relocation of manufacturing capacity to Mexico and the firm's European restructuring.

« Previous month Next month »